Literature DB >> 24577962

Angiotensin II, from vasoconstrictor to growth factor: a paradigm shift.

Sasa Vukelic1, Kathy K Griendling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24577962      PMCID： PMC3985550          DOI： 10.1161/CIRCRESAHA.114.303045

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  31 in total

1.  AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.

Authors:  Sidney C Smith; Emelia J Benjamin; Robert O Bonow; Lynne T Braun; Mark A Creager; Barry A Franklin; Raymond J Gibbons; Scott M Grundy; Loren F Hiratzka; Daniel W Jones; Donald M Lloyd-Jones; Margo Minissian; Lori Mosca; Eric D Peterson; Ralph L Sacco; John Spertus; James H Stein; Kathryn A Taubert
Journal:  Circulation       Date:  2011-11-03       Impact factor: 29.690

2.  Vasoconstrictor-induced protein-tyrosine phosphorylation in cultured vascular smooth muscle cells.

Authors:  T Tsuda; Y Kawahara; K Shii; M Koide; Y Ishida; M Yokoyama
Journal:  FEBS Lett       Date:  1991-07-08       Impact factor: 4.124

3.  Hemodynamic effects of captopril in patients with severe chronic heart failure.

Authors:  T H LeJemtel; E Keung; W H Frishman; H S Ribner; E H Sonnenblick
Journal:  Am J Cardiol       Date:  1982-04-21       Impact factor: 2.778

4.  Myocardin is differentially required for the development of smooth muscle cells and cardiomyocytes.

Authors:  Mark H Hoofnagle; Ronald L Neppl; Erica L Berzin; G C Teg Pipes; Eric N Olson; Brian W Wamhoff; Avril V Somlyo; Gary K Owens
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-25       Impact factor: 4.733

5.  Differential effects of antihypertensive drug therapy on vascular smooth muscle cell hypertrophy, hyperploidy, and hyperplasia in the spontaneously hypertensive rat.

Authors:  G K Owens
Journal:  Circ Res       Date:  1985-04       Impact factor: 17.367

6.  Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.

Authors:  M A Ondetti; B Rubin; D W Cushman
Journal:  Science       Date:  1977-04-22       Impact factor: 47.728

7.  Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

Authors:  M Ravid; R Lang; R Rachmani; M Lishner
Journal:  Arch Intern Med       Date:  1996-02-12

8.  Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells.

Authors:  A A Geisterfer; M J Peach; G K Owens
Journal:  Circ Res       Date:  1988-04       Impact factor: 17.367

9.  Vasoconstriction: a new activity for platelet-derived growth factor.

Authors:  B C Berk; R W Alexander; T A Brock; M A Gimbrone; R C Webb
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

10.  REDUCTION OF ARTERIAL BLOOD PRESSURE OF HYPERTENSIVE PATIENTS AND ANIMALS WITH EXTRACTS OF KIDNEYS.

Authors:  I H Page; O M Helmer; K G Kohlstaedt; P J Fouts; G F Kempf
Journal:  J Exp Med       Date:  1941-01-01       Impact factor: 14.307
View more
  13 in total

Review 1.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

Review 2.  Understanding Angiotensin II Type 1 Receptor Signaling in Vascular Pathophysiology.

Authors:  Satoru Eguchi; Tatsuo Kawai; Rosario Scalia; Victor Rizzo
Journal:  Hypertension       Date:  2018-03-26       Impact factor: 10.190

3.  Expression of active matrix metalloproteinase-9 as a likely contributor to the clinical failure of aclerastide in treatment of diabetic foot ulcers.

Authors:  Trung T Nguyen; Derong Ding; William R Wolter; Matthew M Champion; Dusan Hesek; Mijoon Lee; Rocio L Pérez; Valerie A Schroeder; Mark A Suckow; Shahriar Mobashery; Mayland Chang
Journal:  Eur J Pharmacol       Date:  2018-07-19       Impact factor: 4.432

Review 4.  Oxidative Stress: A Unifying Paradigm in Hypertension.

Authors:  Rhian M Touyz; Francisco J Rios; Rhéure Alves-Lopes; Karla B Neves; Livia L Camargo; Augusto C Montezano
Journal:  Can J Cardiol       Date:  2020-02-24       Impact factor: 5.223

5.  Epigenetics and expression of key genes associated with cardiac fibrosis: NLRP3, MMP2, MMP9, CCN2/CTGF and AGT.

Authors:  Sruti Chandra; Kenneth C Ehrlich; Michelle Lacey; Carl Baribault; Melanie Ehrlich
Journal:  Epigenomics       Date:  2021-02-04       Impact factor: 4.778

Review 6.  Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19.

Authors:  Hao Zhang; Bo Shao; Qin Dang; Zhuang Chen; Quanbo Zhou; Hong Luo; Weitang Yuan; Zhenqiang Sun
Journal:  Front Immunol       Date:  2021-11-10       Impact factor: 7.561

Review 7.  Vascular Endothelial Cells: Heterogeneity and Targeting Approaches.

Authors:  Jan K Hennigs; Christiane Matuszcak; Martin Trepel; Jakob Körbelin
Journal:  Cells       Date:  2021-10-10       Impact factor: 6.600

Review 8.  Renin-angiotensin-system, a potential pharmacological candidate, in acute respiratory distress syndrome during mechanical ventilation.

Authors:  Di Wang; Xiao-Qing Chai; Costan G Magnussen; Graeme R Zosky; Shu-Hua Shu; Xin Wei; Shan-Shan Hu
Journal:  Pulm Pharmacol Ther       Date:  2019-08-01       Impact factor: 3.410

9.  From ACE2 to COVID-19: A multiorgan endothelial disease.

Authors:  Richard A Stein; Lauren M Young
Journal:  Int J Infect Dis       Date:  2020-09-05       Impact factor: 3.623

10.  Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients.

Authors:  Annina S Vischer; Gabriela M Kuster; Raphael Twerenbold; Otmar Pfister; Qian Zhou; Andrea Villiger; Marko Poglitsch; Stephan Krähenbühl; Michael Mayr; Stefan Osswald; Manuel Haschke; Thilo Burkard
Journal:  Cells       Date:  2021-03-03       Impact factor: 6.600
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.